Next, the macrophage transfection experiment revealed that the overexpression of NLRP3 largely counteracted the amelioration of immunodeficiency by the combination in LPS/ATP-induced RAW264.7 macrophages, which further confirmed that the combination exerts the immunomodulatory activity by targeting NLRP3. Here, NLRP3 is linked to immunodeficiency disease.